Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fatty Liver × penclomedine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Obesity 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Fatty Liver 1 Burkitt Lymphoma 1

Interventions

penclomedine 1 atezolizumab 1 Triptorelin Pamoate 1 Tomography, X-Ray Computed 1 Proton Magnetic Resonance Spectroscopy 1 Pancreaticoduodenectomy 1 Orchiectomy 1 Olive Oil 1 Metformin 1 Liquid Biopsy 1 Glucose Tolerance Test 1 Exenatide 1 Excitatory Amino Acids 1 Endosonography 1 Diet, Ketogenic 1 Blood Specimen Collection 1 Bevacizumab 1 Amino Acids, Essential 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157974 2024-06-04

APPLE

University of Colorado, Denver

Phase 2/3 Completed

92 enrolled 17 charts

Fatty Liver, Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡